Business Description
Biosynex SA
ISIN : FR0011005933
Total Employee Number:
273Compare
Compare
Traded in other countries / regions
ALBIO.France0DL.Germany IPO Date
2011-03-21Description
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.76 | |||||
Debt-to-EBITDA | 51.5 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.87 | |||||
Beneish M-Score | -3.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.2 | |||||
3-Year EBITDA Growth Rate | -72.8 | |||||
3-Year FCF Growth Rate | 39.2 | |||||
3-Year Book Growth Rate | -47.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.58 | |||||
9-Day RSI | 43.16 | |||||
14-Day RSI | 46 | |||||
3-1 Month Momentum % | 15.13 | |||||
6-1 Month Momentum % | -3.44 | |||||
12-1 Month Momentum % | -26.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.94 | |||||
Quick Ratio | 1.14 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 231.39 | |||||
Days Sales Outstanding | 29.62 | |||||
Days Payable | 134.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.1 | |||||
Shareholder Yield % | -41.75 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55 | |||||
Operating Margin % | -66.54 | |||||
Net Margin % | -61.16 | |||||
EBITDA Margin % | 1.26 | |||||
FCF Margin % | -9.01 | |||||
OCF Margin % | -6.19 | |||||
ROE % | -109.28 | |||||
ROA % | -36.36 | |||||
ROIC % | -47.54 | |||||
3-Year ROIIC % | 190.17 | |||||
ROC (Joel Greenblatt) % | -219.27 | |||||
ROCE % | -42.11 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.55 | |||||
PS Ratio | 0.18 | |||||
PB Ratio | 0.49 | |||||
EV-to-EBIT | -1.28 | |||||
EV-to-EBITDA | 58.33 | |||||
EV-to-Revenue | 0.74 | |||||
EV-to-FCF | -8.18 | |||||
Price-to-GF-Value | 0.38 | |||||
Price-to-Projected-FCF | 0.34 | |||||
Price-to-Median-PS-Value | 0.16 | |||||
Earnings Yield (Greenblatt) % | -78.5 | |||||
FCF Yield % | -51.56 | |||||
Forward Rate of Return (Yacktman) % | 140.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biosynex SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 95.194 | ||
| EPS (TTM) (€) | -4.03 | ||
| Beta | 0.6965 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.96 | ||
| Volatility % | 91.89 | ||
| 14-Day RSI | 46 | ||
| 14-Day ATR (€) | 0.030435 | ||
| 20-Day SMA (€) | 0.9119 | ||
| 12-1 Month Momentum % | -26.99 | ||
| 52-Week Range (€) | 0.455 - 1.57 | ||
| Shares Outstanding (Mil) | 18.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biosynex SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biosynex SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biosynex SA Frequently Asked Questions
What is Biosynex SA(XPAR:ALBIO)'s stock price today?
The current price of XPAR:ALBIO is €0.90. The 52 week high of XPAR:ALBIO is €1.57 and 52 week low is €0.46.
When is next earnings date of Biosynex SA(XPAR:ALBIO)?
The next earnings date of Biosynex SA(XPAR:ALBIO) is .
Does Biosynex SA(XPAR:ALBIO) pay dividends? If so, how much?
Biosynex SA(XPAR:ALBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biosynex SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers